India Pesticides Ltd (IPL) — shareholding pattern, promoter holding, financials and share price

About India Pesticides Ltd (IPL)

India Pesticides Ltd operates in the Pesticides & Agrochemicals industry, within the Chemicals sector. It trades on the NSE as IPL and on the BSE under scrip code 543311. Its ISIN is INE0D6701023.

India Pesticides Limited is one of the globally operating agro-chemical manufactures in India, since 1984. The company is the sole Indian manufacturer and among the top five manufacturers globally for several Technicals, such as Folpet, Thiocarbamate Herbicide, and several other products [1]

India Pesticides Limited is an R&D-driven Indian agrochemical manufacturer producing technicals, APIs and a growing formulations business; it operates two main manufacturing sites in Uttar Pradesh (Dewa Road and Sandila) with a 100% subsidiary Shalvis Specialities and two DSIR-registered R&D labs supporting product development and global registrations.

Financial momentum is strong: Q3 FY2026 revenue reached INR229 crore (▲31% YoY) and 9M revenue was INR808 crore (▲28% YoY), with EBITDA margins near 18% and PAT margins around 10–11%; export contribution is material (~41% of turnover) and the company reported operating leverage and volume-led growth in Q3.

Listed peers in Pesticides & Agrochemicals: Bharat Rasayan Ltd, Insecticides India Ltd, Astec Lifesciences Ltd, Punjab Chemicals & Crop Protection Ltd, Meghmani Organics Ltd, Dharmaj Crop Guard Ltd.

Valuation & Returns

10 Jul 2026

At ₹157.45 a share on 10 Jul 2026, India Pesticides Ltd (IPL) was valued at a price-to-earnings ratio of 15.13x against an industry P/E of 22.12x and a price-to-book of 2.02x on a book value of ₹78.01 per share as of Mar 2025. Solomo computes return on equity of 13.34% and return on capital employed of 18.08% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.

P/E
15.13x
Industry P/E
22.12x
P/B
2.02x
EPS (TTM)
₹10.41
Book value / share
₹78.01
ROE
13.34%
ROCE
18.08%
ROA
10.49%
Debt / equity
0.07x
Dividend yield
0.48%
EBITDA margin
18.39%
52-week range
₹124.65 – ₹245.95

Ratios are computed from filed results and the last recorded price. Not investment advice.

Financial Performance

Mar 2026

In the year ended Mar 2026, India Pesticides Ltd (IPL) reported revenue of ₹1,057 crore, net profit of ₹120 crore and earnings per share of ₹10.41. That compares with revenue of ₹829 crore and net profit of ₹82 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.

In the quarter ended Mar 2026, revenue was ₹266 crore and net profit ₹31 crore (consolidated).

Consolidated annual results for India Pesticides Ltd (IPL), Mar 2022 to Mar 2026. Revenue and net profit in ₹ crore; EPS in ₹ per share.
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue (₹ cr)7168856808291,057
Net profit (₹ cr)1581436082120
EPS (₹)13.7212.445.227.1410.41
Compound annual growth for India Pesticides Ltd (IPL). Stock price CAGR is price return and excludes dividends.
Measure5Y3Y1Y
Sales growth11.57%5.00%21.78%
Profit growth3.57%-18.94%36.58%
Stock price CAGR-14%-11%-27%

Ownership Summary

Jun 2026

As of Jun 2026, promoters hold 63.65% of India Pesticides Ltd (IPL) (unchanged from the previous quarter), foreign institutional investors (FII) hold 0.2% and domestic institutional investors (DII) hold 0.03%. Market capitalisation was ₹1,813 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Jun 2021.

Largest disclosed public shareholders in Jun 2026: ASHA AGARWAL 3.16%, NUPUR GOYAL 2.11%, SUGANDHA SWARUP ARORA 2.11%, APARNA GUPTA 2.11%, SHALINI PAWAN AGARWAL 1.01%, SONIA AJAY GOYAL 1.01%. Only stakes above the 1% disclosure threshold are named in filings.

QuarterPromoterPledgedFIIDIIPublic
Jun 202663.65%-0.2%0.03%36.35%
Mar 202663.65%-1.87%0.02%36.35%
Dec 202563.65%-1.88%0.04%36.35%
Sep 202563.65%-2.78%0.03%36.35%
Jun 202563.62%-2.52%0%36.38%
Mar 202563.61%-1.85%-36.39%
Dec 202463.61%-1.75%0.06%36.39%
Sep 202463.61%-0.32%0.05%36.39%
Every quarter since Jun 2021 Filing data, not investment advice.